Serine Protease Inhibitors Restrict Host Susceptibility to SARS-CoV-2 Infections.
mBio
; 13(3): e0089222, 2022 06 28.
Article
in En
| MEDLINE
| ID: mdl-35532162
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Antiviral Agents
/
Serine Proteinase Inhibitors
/
Serpins
/
COVID-19 Drug Treatment
Type of study:
Prognostic_studies
/
Risk_factors_studies
Limits:
Humans
Language:
En
Journal:
MBio
Year:
2022
Document type:
Article
Affiliation country:
Sweden
Country of publication:
United States